Borealis advancing sustainability medical devices with the Bornewables
The Protect VL project was born out of a vision to reduce the environmental footprint of medical devices
The Protect VL project was born out of a vision to reduce the environmental footprint of medical devices
Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
The distribution agreement is effective from 1 October 2021 and applies to Bormed products used in pharmaceutical packaging, medical and diagnostic devices
Subscribe To Our Newsletter & Stay Updated